A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

440

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

March 31, 2006

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

Gabitril

Trial Locations (21)

10021

Social Psychiatry Research Inst., New York

10024

The Medical Research Network, New York

11235

Social Psychiatry Research Inst., Brooklyn

11559

Neurobehavioral Research, Inc., Lawrence

19104

University of Pennsylvania, Philadelphia

22201

Comprehensive Neuroscience of Northern Virginia, Arlington

29201

Carolina Clinical Research Services, Columbia

30080

Carman Research, Smyrna

35216

Birmingham Research Group, Birmingham

41042

Hartford Research Group, Florence

44122

Northcoast Clinical Trials, Beachwood

48864

Summit Research Network, Okemos

73104

University of Oklahoma Health Sciences Center, Oklahoma City

90210

Southwestern Research Institute, Beverly Hills

91324

Pharmacology Research Institute, Northridge

92868

Pacific Clinical Research, Orange

96826

Hawaii Clinical Research Center, Honolulu

97209

Summit Research Network, Portland

98104

Summit Research Network, Seattle

08021

CNS Research Institute, Clementon

84107-7591

Radiant Research, Salt Lake City, Salt Lake City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cephalon

INDUSTRY

NCT00236067 - A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder | Biotech Hunter | Biotech Hunter